Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
出版年份 2017 全文链接
标题
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 9, Pages 1967
出版商
MDPI AG
发表日期
2017-09-14
DOI
10.3390/ijms18091967
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
- (2017) Robert L Coleman et al. LANCET ONCOLOGY
- Targeting the tumour microenvironment in ovarian cancer
- (2016) Jean M. Hansen et al. EUROPEAN JOURNAL OF CANCER
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment
- (2014) Melissa K. Brunckhorst et al. AMERICAN JOURNAL OF PATHOLOGY
- PDGF receptor signaling networks in normal and cancer cells
- (2014) Jean-Baptiste Demoulin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The emerging role of anti-angiogenic therapy in ovarian cancer
- (2014) VINCENZA CONTEDUCA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
- (2014) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer
- (2013) Elisabeth Chéreau et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
- (2013) Nikos Gavalas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
- (2013) Takamitsu Sasaki et al. Biomed Research International
- Role of angiogenesis in the pathogenesis of cancer
- (2012) Paulo M. Hoff et al. CANCER TREATMENT REVIEWS
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- BMP-2 signaling in ovarian cancer and its association with poor prognosis
- (2009) Cécile Le Page et al. Journal of Ovarian Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started